Munich Re and Swiss Re are taking a lead on pressing the case that contract terms will militate against successful Covid-19 BI claims on many excess-of-loss (XoL) cat treaties, raising the spectre of some cedants being unable to recover...
Munich Re, Swiss Re and the multi-billion Covid-19 BI question
